Other
Effectiveness
0
Pipeline Programs↗
110
Active Trials↗
84
Companies Involved↗
Effectiveness is an early-stage landscape with 0 programs across 84 companies. The most active players are GSK, Merck & Co., Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
888
clinical trials
Completed569 · 64%
Unknown status116 · 13%
Recruiting61 · 7%
Terminated59 · 7%
Withdrawn27 · 3%
Not yet recruiting26 · 3%
Other30 · 3%
Clinical Trials
Trial Activity
888 trials
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Recruiting·IInstituto de Investigación Hospital Universitario La Paz·Phase 4·NCT06701825·114 enrolled
Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China
Recruiting·—·N/A·NCT07271342·10,000 enrolled
The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial
Recruiting·UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology·Phase 2/3·NCT06785571·204 enrolled
Page 1 of 60
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)